Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late

Adriano M. Pellicelli, Marzia Montalbano, Raffaella Lionetti, Christine Durand, Peter Ferenci, Gianpiero D'Offizi, Viola Knop, Andrea Telese, Ilaria Lenci, Arnaldo Andreoli, Stefan Zeuzem, Mario Angelico

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late'. Together they form a unique fingerprint.

Medicine & Life Sciences